BIONUMERIK $6 MIL. DRUG DESIGN CRADA WITH LAWRENCE LIVERMORE LAB
BIONUMERIK $6 MIL. DRUG DESIGN CRADA WITH LAWRENCE LIVERMORE LAB will focus on developing faster pharmaceutical discovery software able to run on high-performance parallel computer systems for the design of cancer and cardiovascular drugs. At a June 15 Capitol Hill press conference held by Sen. Boxer (D-Calif.), and Everet Beckner, PhD, principal deputy assistant secretary for defense programs for the Department of Energy, which runs Lawrence Livemore National Laboratory, said DoE would provide $3 mil. over three years toward the research, with San Antonio-based BioNumerik contributing the remaining $3 mil.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth